Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Julia F. Kuder"'
Autor:
Rafael Diaz, Stephen D. Wiviott, Marc S. Sabatine, Jindřich Špinar, Itamar Raz, Assen Goudev, Ofri Mosenzon, Deepak L. Bhatt, Avivit Cahn, Ingrid Gause-Nilsson, Kyong-Soo Park, Darren K. McGuire, Kazuma Oyama, Sabina A. Murphy, Lawrence A. Leiter, John P.H. Wilding, Julia F Kuder
Publikováno v:
European Heart Journal. 43:2958-2967
Aims We investigated the associations between obesity, cardiorenal events, and benefits of dapagliflozin in patients with type 2 diabetes mellitus (T2DM). Methods and results DECLARE–TIMI 58 randomized patients with T2DM and either atherosclerotic
Autor:
Andrew Hamer, Anthony C Keech, Remo H.M. Furtado, Julia F Kuder, Huei Wang, Antonio Fagundes, Thomas A Zelniker, Brian A. Bergmark, Kazuma Oyama, Sabina A. Murphy, Robert P. Giugliano, Minao Tang, Marc S. Sabatine
Publikováno v:
Journal of the American College of Cardiology. 77(3)
This study sought to evaluate the ability of the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor evolocumab to reduce the risk of complex coronary atherosclerosis requiring revascularization.PCSK9 inhibitors induce plaque regression a
Autor:
Basil S. Lewis, Michelle L. O'Donoghue, Kurt Huber, Julia F Kuder, Ioanna Gouni-Berthold, Zbigniew Gaciong, Robert P. Giugliano, Brian A. Bergmark, François Mach, J. Wouter Jukema, S. Lale Tokgozoglu, Terje R. Pedersen, Richard Ceska, Marc S. Sabatine, Marat V. Ezhov, Henrik Jensen, Sabina A. Murphy, Francois Schiele
Publikováno v:
JAMA Cardiology, 5(6), 709-713. AMER MEDICAL ASSOC
Bergmark, B A, O'Donoghue, M L, Murphy, S A, Kuder, J F, Ezhov, M V, Češka, R, Gouni-Berthold, I, Jensen, H K, Tokgozoglu, S L, MacH, F, Huber, K, Gaciong, Z, Lewis, B S, Schiele, F, Jukema, J W, Pedersen, T R, Giugliano, R P & Sabatine, M S 2020, ' An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial ', JAMA cardiology, vol. 5, no. 6, pp. 709-713 . https://doi.org/10.1001/jamacardio.2020.0728
Bergmark, B A, O'Donoghue, M L, Murphy, S A, Kuder, J F, Ezhov, M V, Češka, R, Gouni-Berthold, I, Jensen, H K, Tokgozoglu, S L, MacH, F, Huber, K, Gaciong, Z, Lewis, B S, Schiele, F, Jukema, J W, Pedersen, T R, Giugliano, R P & Sabatine, M S 2020, ' An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial ', JAMA cardiology, vol. 5, no. 6, pp. 709-713 . https://doi.org/10.1001/jamacardio.2020.0728
Importance: Despite recent advances in treatment of severe aortic valve stenosis (AS), AS remains a life-threatening condition with no proven disease-modifying therapy. Low-density lipoprotein cholesterol (LDL-C) and lipoprotein(a) (Lp[a]) have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03bccde28752cb22a797d14b02ade1c4
http://hdl.handle.net/1887/3232705
http://hdl.handle.net/1887/3232705
Autor:
Petr Jarolim, Marc A. Pfeffer, Julia F Kuder, Brian A. Bergmark, David A. Morrow, Marc S. Sabatine, Scott D. Solomon, Eugene Braunwald, Jacob A. Udell
AIMS Klotho, an essential co-receptor for fibroblast growth factor (FGF)-23, has potentially beneficial inhibitory effects on the renin-angiotensin system. Limited data exist on the prognostic value of Klotho and FGF-23 levels in combination or their
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45d872158b157a55c46b22e93dc70514
https://europepmc.org/articles/PMC6458082/
https://europepmc.org/articles/PMC6458082/
Autor:
Stephen D. Wiviott, Julia F Kuder, Eva C. Jensen, Andrzej Budaj, Giulia Magnani, Alexander Parkhomenko, Eugene Braunwald, Robert F. Storey, Marc S. Sabatine, Jose Lopez-Sendon, Marc P. Bonaca, Per Johanson, Assen Goudev, Frans Van de Werf, Jose C. Nicolau, KyungAh Im, Marc Cohen, Deepak L. Bhatt, P. Gabriel Steg, Ramón Corbalán, Christian W. Hamm, Mikael Dellborg, David A. Morrow, Rafael Diaz
Publikováno v:
Journal of the American Heart Association. 7
Background Ticagrelor reduced cardiovascular death, myocardial infarction (MI), or stroke in patients with prior MI in PEGASUS‐TIMI 54 (Prevention of Cardiovascular Events [eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke] in Patie
Autor:
Peter W.F. Wilson, Kim A. Eagle, Shinya Goto, Sidney C. Smith, E. Magnus Ohman, KyungAh Im, Julia F Kuder, Deepak L. Bhatt, Matthew A. Cavender, Ph. Gabriel Steg
Publikováno v:
Circulation. 132:923-931
Background— Despite the known association of diabetes mellitus with cardiovascular events, there are few contemporary data on the long-term outcomes from international cohorts of patients with diabetes mellitus. We sought to describe cardiovascular
Autor:
Michelle L. O'Donoghue, Andrzej Budaj, Jacob A. Udell, Eugene Braunwald, David A. Morrow, Marc S. Sabatine, Brian A. Bergmark, Christian W. Hamm, Petr Jarolim, KyungAh Im, Dylan L. Steen, Jianping Guo, Julia F Kuder, Christopher P. Cannon
Publikováno v:
JAMA cardiology. 3(6)
IMPORTANCE: Elevated fibroblast growth factor 23 (FGF-23) concentrations are associated with myocardial fibrosis and renin-angiotensin system upregulation, potentially providing prognostic information distinct from standard cardiovascular (CV) biomar
Autor:
Ramón Corbalán, Peter Held, Mikael Dellborg, Robert F. Storey, Eugene Braunwald, Félix Medina, Eva C. Jensen, Deepak L. Bhatt, KyungAh Im, Assen Goudev, Marc P. Bonaca, Daniel Isaza, Marc Cohen, Philip E. Aylward, Giulia Magnani, Diego Ardissino, Frederic Kontny, Alexander Parkhomenko, Julia F Kuder, Marc S. Sabatine, Gabriel Steg
Publikováno v:
European heart journal. 37(4)
Aims We evaluated the relationship of renal function and ischaemic and bleeding risk as well as the efficacy and safety of ticagrelor in stable patients with prior myocardial infarction (MI). Methods and results Patients with a history of MI 1–3 ye
Autor:
Andrzej Budaj, Michelle L. O'Donoghue, Róbert Gábor Kiss, Julia F Kuder, Jean Francois Tanguay, John J. Lepore, Frantisek Kovar, Matthew A. Cavender, Marc P. Bonaca, Jose Lopez-Sendon, Jindrich Spinar, Marc S. Sabatine, Mikael Dellborg, Pierre Théroux, Ruchira Glaser, Jorge Antonio Gutierrez, Jennifer B. Shannon, Christian W. Hamm, Keith A.A. Fox, P. Gabriel Steg, Philip E. Aylward, Ton Oude Ophuis, Ian Laws, Kyung Ah Im, David A. Morrow, Alexandr Parkhomenko, Stephen D. Wiviott, Richard Davies, Latitude-Timi Investigators, Mikhail Ruda
Publikováno v:
JAMA. 315:1591
Importance p38 Mitogen-activated protein kinase (MAPK)–stimulated inflammation is implicated in atherogenesis, plaque destabilization, and maladaptive processes in myocardial infarction (MI). Pilot data in a phase 2 trial in non–ST elevation MI i